Your browser doesn't support javascript.
loading
Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events.
Huang, Zhaoliang; Pang, Xinghua; Zhong, Tingting; Qu, Tailong; Chen, Na; Ma, Shun; He, Xinrong; Xia, Dennis; Wang, Max; Xia, Michelle; Li, Baiyong.
Afiliação
  • Huang Z; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Pang X; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Zhong T; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Qu T; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Chen N; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Ma S; Chemical Manufacturing and Control Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • He X; Chemical Manufacturing and Control Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Xia D; Manufacturing and Quality Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Wang M; Procurement and Sourcing Department and Clinical Operation Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Xia M; Akeso Biopharma Co., Ltd., Zhongshan, China.
  • Li B; Research and Development Department, Akeso Biopharma Co., Ltd., Zhongshan, China.
Front Immunol ; 13: 924542, 2022.
Article em En | MEDLINE | ID: mdl-35833116
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Citotoxicidade Celular Dependente de Anticorpos Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Citotoxicidade Celular Dependente de Anticorpos Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China